Making a difference to the people we help treat by creating value and improving healthcare outcomes through connecting innovative manufacturers with Australasian customers.

Shayne Christensen appointed new CEO of Abacus ALS

Products are for professional/laboratory use only.

Abacus ALS, the Brisbane based distributor of pathology and research laboratory instruments and consumables has announced that Shayne Christensen has been appointed Chief Executive Officer (CEO), effective January 1st 2013.

Christensen joined Abacus in June 2004 and since this time in his roles as National Sales Manager and more recently as Sales and Marketing Manager has been integral to the growth and success of the organisation.  Shayne will take over from Bruce Evans who announced in July that he would vacate the Managing Director’s position at the end of 2012.



Request a Quote

Request Quote

Recent Posts

Empowering Resilience with the Paraplegic Benefit Fund

Abacus dx believes in resilience and supporting our community. This commitment is evident in our partnership with the Paraplegic Benefit Fund (PBF), which is dedicated…

Read full article

Press Release: Abacus dx Announces Partnership with Inpeco

Abacus dx Announces Distribution Partnership with Inpeco in Australia Brisbane, Australia – February 17, 2025 (more…)

Read full article

Press Release: Abacus dx Announces Partnership with Response Biomedical

Abacus dx Announces Commercial Partnership with Response Biomedical in Australia & New Zealand’s Clinical Market Sector Brisbane, 6th November 2024 (more…)

Read full article